eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleLeukemia
Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia
- Tatiana Perova1,2,
- Ildiko Grandal1,
- Lauryl M. J. Nutter1,
- Eniko Papp1,2,
- Irina R. Matei1,2,
- Joseph Beyene3,
- Paul E. Kowalski1,
- Johann K. Hitzler1,4,
- Mark D. Minden2,5,
- Cynthia J. Guidos1,6 and
- Jayne S. Danska2,7,*
- 1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
- 2Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
- 3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario L8S 4L8, Canada.
- 4Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
- 5Ontario Cancer Institute and Princess Margaret Hospital, University Health Network, Toronto, Ontario M5T 2M9, Canada.
- 6Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
- 7Program in Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
- ↵*Corresponding author. E-mail: jayne.danska{at}sickkids.ca
See allHide authors and affiliations
Science Translational Medicine 14 May 2014:
Vol. 6, Issue 236, pp. 236ra62
DOI: 10.1126/scitranslmed.3008661
Vol. 6, Issue 236, pp. 236ra62
DOI: 10.1126/scitranslmed.3008661
Tatiana Perova
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Ildiko Grandal
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
Lauryl M. J. Nutter
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
Eniko Papp
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Irina R. Matei
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Joseph Beyene
3Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario L8S 4L8, Canada.
Paul E. Kowalski
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
Johann K. Hitzler
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
4Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
Mark D. Minden
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
5Ontario Cancer Institute and Princess Margaret Hospital, University Health Network, Toronto, Ontario M5T 2M9, Canada.
Cynthia J. Guidos
1Program in Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
6Department of Immunology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
Jayne S. Danska
2Department of Medical Biophysics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.
7Program in Genetics & Genome Biology, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
Submit a Response to This Article
No eLetters have been published for this article.